Company profile for Notable Labs

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Notable is a clinical-stage precision therapeutics company developing a new class of oncology medicines: Predictive Precision Medicines.Notable’s predictive technology platform can identify — from a blood sample taken before treatment — whether a patient will positively respond to a given treatment. This enables Notable and its mission-driven team across therapeutics, diagnostics and engineering to focus its clinical d...
Notable is a clinical-stage precision therapeutics company developing a new class of oncology medicines: Predictive Precision Medicines.Notable’s predictive technology platform can identify — from a blood sample taken before treatment — whether a patient will positively respond to a given treatment. This enables Notable and its mission-driven team across therapeutics, diagnostics and engineering to focus its clinical development programs solely on responding patients and achieve predictive medicines precisely for them.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
320 Hatch Drive, Foster City, CA 94404
Telephone
Telephone
(415) 851-2410
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/08/29/2937696/0/en/Notable-Labs-to-Present-Data-on-September-4th-at-SOHO-2024.html

GLOBENEWSWIRE
29 Aug 2024
Notable Labs Announces CEO Transition
Notable Labs Announces CEO Transition

26 Aug 2024

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2024/08/26/2935803/0/en/Notable-Labs-Announces-CEO-Transition.html

GLOBENEWSWIRE
26 Aug 2024

https://www.globenewswire.com/news-release/2024/07/24/2917910/0/en/Notable-Labs-Receives-FDA-Clearance-to-Proceed-Further-with-Volasertib-Phase-2-Study.html

GLOBENEWSWIRE
24 Jul 2024

https://www.globenewswire.com/news-release/2024/05/09/2879200/0/en/Notable-Labs-to-Participate-in-Fireside-Chat-at-the-Citizens-JMP-Securities-Life-Sciences-Conference-2024.html

GLOBENEWSWIRE
09 May 2024

https://www.globenewswire.com/news-release/2024/04/12/2862139/0/en/Notable-Labs-Reports-2023-Financial-Results-and-Provides-a-Business-Update.html

GLOBENEWSWIRE
12 Apr 2024

https://www.globenewswire.com/news-release/2024/04/09/2860412/0/en/Notable-Labs-Presents-the-Design-Plan-for-the-PPMP-Enabled-Phase-2-Trial-with-Volasertib-for-Relapsed-Refractory-AML-at-AACR-2024.html

GLOBENEWSWIRE
09 Apr 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty